Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Role of Leptin in Non-Alcoholic Fatty Liver Disease
Carlos Jiménez‐Cortegana, Alba García-Galey, Malika Tami, et al.
Biomedicines (2021) Vol. 9, Iss. 7, pp. 762-762
Open Access | Times Cited: 70

Showing 1-25 of 70 citing articles:

An adipocentric perspective on the development and progression of non-alcoholic fatty liver disease
Eun Young Lee, Hannelie Korf, Antonio Vidal‐Puig
Journal of Hepatology (2023) Vol. 78, Iss. 5, pp. 1048-1062
Open Access | Times Cited: 96
Adipokines in Non-Alcoholic Fatty Liver Disease: Are We on the Road toward New Biomarkers and Therapeutic Targets?
Vera Francisco, María‐Jesús Sanz, José T. Real, et al.
Biology (2022) Vol. 11, Iss. 8, pp. 1237-1237
Open Access | Times Cited: 50
Non-Alcoholic Steatohepatitis (NASH) and Organokines: What Is Now and What Will Be in the Future
João Paulo Margiotti dos Santos, Mariana Canevari de Maio, Monike Alves Lemes, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 1, pp. 498-498
Open Access | Times Cited: 37
Molecular Mechanisms of Western Diet-Induced Obesity and Obesity-Related Carcinogenesis—A Narrative Review
Dhruvi Lathigara, Devesh Kaushal, Robert Wilson
Metabolites (2023) Vol. 13, Iss. 5, pp. 675-675
Open Access | Times Cited: 32
The Interconnection between Hepatic Insulin Resistance and Metabolic Dysfunction-Associated Steatotic Liver Disease—The Transition from an Adipocentric to Liver-Centric Approach
Milena Vesković, Nikola Šutulović, Dragan Hrnčić, et al.
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 11, pp. 9084-9102
Open Access | Times Cited: 24
Bioactive Compounds in Moringa oleifera: Mechanisms of Action, Focus on Their Anti-Inflammatory Properties
Adina Chiş, Paul Aimé Noubissi, Oana Lelia Pop, et al.
Plants (2023) Vol. 13, Iss. 1, pp. 20-20
Open Access | Times Cited: 21
Dysmetabolic comorbidities and non-alcoholic fatty liver disease: a stairway to metabolic dysfunction-associated steatotic liver disease
Carmen Colaci, Maria Luisa Gambardella, Giuseppe Guido Maria Scarlata, et al.
Hepatoma Research (2024) Vol. 10, pp. 16-16
Open Access | Times Cited: 12
Diabetes as a risk factor for MASH progression
Sofiya Gancheva, Michael Roden, Laurent Castéra
Diabetes Research and Clinical Practice (2024) Vol. 217, pp. 111846-111846
Open Access | Times Cited: 8
The role of novel adipokines and adipose-derived extracellular vesicles (ADEVs): Connections and interactions in liver diseases
Lijun Xie, Huiying Wang, Jinying Hu, et al.
Biochemical Pharmacology (2024) Vol. 222, pp. 116104-116104
Open Access | Times Cited: 5
Adipokines regulate the development and progression of MASLD through organellar oxidative stress
Ke Zhao, Heng Zhang, Wenyu Ding, et al.
Hepatology Communications (2025) Vol. 9, Iss. 2
Open Access
Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Children with Obesity: An Obesity Medicine Association (OMA) and Expert Joint Perspective 2025
Jennifer Panganiban, Mohit Kehar, Samar H. Ibrahim, et al.
Obesity Pillars (2025), pp. 100164-100164
Open Access
The role of liver sinusoidal endothelial cells in metabolic dysfunction-associated steatotic liver diseases and liver cancer: mechanisms and potential therapies
Hanjun Mo, Pengfei Yue, Qiaoqi Li, et al.
Angiogenesis (2025) Vol. 28, Iss. 2
Closed Access
Hepatocellular Carcinoma and Obesity, Type 2 Diabetes Mellitus, Cardiovascular Disease: Causing Factors, Molecular Links, and Treatment Options
Chunye Zhang, Shuai Liu, Ming Yang
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 35
Recent evaluation about inflammatory mechanisms in nonalcoholic fatty liver disease
Chong Song, Xian Long, Jianbin He, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 13
Association between leptin and NAFLD: a two-sample Mendelian randomization study
Ziwei Guo, Hongbo Du, Yi Guo, et al.
European journal of medical research (2023) Vol. 28, Iss. 1
Open Access | Times Cited: 12
Role of Perturbated Hemostasis in MASLD and Its Correlation with Adipokines
Salvatore Pezzino, Tonia Luca, M. Castorina, et al.
Life (2024) Vol. 14, Iss. 1, pp. 93-93
Open Access | Times Cited: 4
Association between triglyceride to high-density lipoprotein cholesterol ratio and nonalcoholic fatty liver disease and liver fibrosis in American adults: an observational study from the National Health and Nutrition Examination Survey 2017–2020
Jianjun Wang, Han Li, Xiaoyi Wang, et al.
Frontiers in Endocrinology (2024) Vol. 15
Open Access | Times Cited: 4
Non-alcoholic fatty liver disease: a multi-system disease influenced by ageing and sex, and affected by adipose tissue and intestinal function
Josh Bilson, Jaswinder K. Sethi, Christopher D. Byrne
Proceedings of The Nutrition Society (2021) Vol. 81, Iss. 2, pp. 146-161
Open Access | Times Cited: 27
Role of Leptin as a Link between Asthma and Obesity: A Systematic Review and Meta-Analysis
Helena Sánchez-Ortega, Carlos Jiménez‐Cortegana, José Pedro Novalbos Ruiz, et al.
International Journal of Molecular Sciences (2022) Vol. 24, Iss. 1, pp. 546-546
Open Access | Times Cited: 19
Adipose tissue insulin resistance exacerbates liver inflammation and fibrosis in a diet-induced NASH model
Yusei Hosokawa, Tetsuya Hosooka, Makoto Imamori, et al.
Hepatology Communications (2023) Vol. 7, Iss. 6
Open Access | Times Cited: 10
Serum Metrnl is Decreased in Metabolic Dysfunction-Associated Fatty Liver Disease: A Case-Control Study
Mei Liu, Xiangqian Gao, Yang Tian, et al.
Diabetes Metabolic Syndrome and Obesity (2024) Vol. Volume 17, pp. 533-543
Open Access | Times Cited: 3
High-Fat Diet Delays Liver Fibrosis Recovery and Promotes Hepatocarcinogenesis in Rat Liver Cirrhosis Model
Daisuke Taguchi, Yohei Shirakami, Hiroyasu Sakai, et al.
Nutrients (2024) Vol. 16, Iss. 15, pp. 2506-2506
Open Access | Times Cited: 3
Analysis of miRNAs Profiles in Serum of Patients With Steatosis and Steatohepatitis
Maria Vulf, Daria Skuratovskaia, Alexandra Komar, et al.
Frontiers in Cell and Developmental Biology (2021) Vol. 9
Open Access | Times Cited: 25
Lactobacillus reuteri MJM60668 Prevent Progression of Non-Alcoholic Fatty Liver Disease through Anti-Adipogenesis and Anti-Inflammatory Pathway
Pia Werlinger, Huong Thi Nguyen, Mingkun Gu, et al.
Microorganisms (2022) Vol. 10, Iss. 11, pp. 2203-2203
Open Access | Times Cited: 17
Targeting the Adipose Tissue–Liver–Gut Microbiota Crosstalk to Cure MASLD
Daniela Gabbia, Sara De Martin
Biology (2023) Vol. 12, Iss. 12, pp. 1471-1471
Open Access | Times Cited: 9
Page 1 - Next Page

Scroll to top